At 12 months, the median hs-CRP level was 37% lower in the
rosuvastatin group compared to placebo, from a baseline level
of 2.2 mg/l,
and median LDL cholesterol was 50% lower in the rosuvastatin group compared to placebo, from a baseline level of 186 mg/dl.
I do agree, lifestyle changes should always be the first line of defense for high cholesterol. However, in cases where that doesn't work, statins make sense.